Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $265,187 | 118 | 68.4% |
| Consulting Fee | $51,963 | 20 | 13.4% |
| Travel and Lodging | $51,957 | 229 | 13.4% |
| Food and Beverage | $18,288 | 706 | 4.7% |
| Education | $394.93 | 13 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $148,334 | 272 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $124,060 | 236 | $0 (2022) |
| Merck Sharp & Dohme LLC | $52,432 | 95 | $0 (2023) |
| Axsome Therapeutics, Inc. | $49,403 | 69 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $4,898 | 26 | $0 (2024) |
| LivaNova USA, Inc. | $1,320 | 6 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $1,151 | 57 | $0 (2024) |
| ABBVIE INC. | $1,134 | 64 | $0 (2024) |
| Allergan, Inc. | $653.58 | 37 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $650.83 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $95,399 | 169 | Janssen Pharmaceuticals, Inc ($48,216) |
| 2023 | $64,093 | 189 | Janssen Pharmaceuticals, Inc ($51,985) |
| 2022 | $15,603 | 100 | Janssen Pharmaceuticals, Inc ($14,002) |
| 2021 | $10,625 | 103 | Janssen Pharmaceuticals, Inc ($9,248) |
| 2020 | $10,850 | 94 | Janssen Pharmaceuticals, Inc ($7,835) |
| 2019 | $35,737 | 101 | Sunovion Pharmaceuticals Inc. ($18,185) |
| 2018 | $73,306 | 176 | Sunovion Pharmaceuticals Inc. ($63,559) |
| 2017 | $82,176 | 154 | Sunovion Pharmaceuticals Inc. ($41,146) |
All Payment Transactions
1,086 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Neuropsychiatry | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $24.75 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $43.82 | General |
| Category: Central Nervous System | ||||||
| 12/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $3,125.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Travel and Lodging | In-kind items and services | $825.44 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | Cash or cash equivalent | $38.95 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/02/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: Neuroscience | ||||||
| 11/27/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $25.60 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Neuropsychiatry | ||||||
| 11/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/28/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,875.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/28/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Travel and Lodging | Cash or cash equivalent | $54.60 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/28/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | Cash or cash equivalent | $17.05 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Neuropsychiatry | ||||||
| 10/21/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MYCITE (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,875.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/17/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $17.04 | General |
| Category: ADHD | ||||||
| 10/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Travel and Lodging | Cash or cash equivalent | $9.38 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/14/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Psychology/Psychiatric | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 108 | 263 | $54,201 | $17,264 |
| 2022 | 7 | 235 | 405 | $132,341 | $32,064 |
| 2021 | 6 | 280 | 549 | $192,132 | $42,002 |
| 2020 | 8 | 422 | 756 | $248,095 | $50,769 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 213 | $37,271 | $11,394 | 30.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 25 | 26 | $10,924 | $3,649 | 33.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 24 | $6,006 | $2,221 | 37.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 69 | 188 | $32,805 | $11,289 | 34.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 35 | 35 | $21,000 | $5,438 | 25.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 53 | 90 | $45,000 | $4,968 | 11.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 24 | 24 | $9,038 | $3,534 | 39.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 32 | $7,890 | $2,793 | 35.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 24 | 25 | $12,500 | $2,536 | 20.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $4,108 | $1,507 | 36.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 68 | 230 | $40,006 | $14,137 | 35.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 84 | 170 | $85,000 | $9,629 | 11.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 55 | 58 | $29,000 | $6,296 | 21.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 38 | 38 | $22,800 | $6,024 | 26.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 32 | $7,534 | $2,970 | 39.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 20 | 21 | $7,792 | $2,946 | 37.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 110 | 234 | $117,000 | $13,400 | 11.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 88 | 232 | $39,374 | $11,095 | 28.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 68 | 68 | $34,000 | $7,338 | 21.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 51 | 93 | $18,792 | $6,906 | 36.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 33 | 35 | $21,000 | $5,433 | 25.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 28 | 29 | $10,796 | $3,050 | 28.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 29 | 46 | $4,680 | $2,595 | 55.4% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 15 | 19 | $2,453 | $950.72 | 38.8% |
About Dr. Prashant Gajwani, MD
Dr. Prashant Gajwani, MD is a Psychiatry healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770509283.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Prashant Gajwani, MD has received a total of $387,789 in payments from pharmaceutical and medical device companies, with $95,399 received in 2024. These payments were reported across 1,086 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($265,187).
As a Medicare-enrolled provider, Gajwani has provided services to 1,045 Medicare beneficiaries, totaling 1,973 services with total Medicare billing of $142,099. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Houston, TX
- Active Since 07/15/2006
- Last Updated 02/22/2012
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1770509283
Products in Payments
- SPRAVATO (Drug) $147,691
- LATUDA (Drug) $124,026
- BELSOMRA (Drug) $52,418
- Auvelity (Drug) $49,403
- VRAYLAR (Drug) $1,788
- VNS Therapy (Device) $1,170
- REXULTI (Drug) $1,032
- INVEGA SUSTENNA (Drug) $674.66
- INGREZZA (Drug) $647.85
- CAPLYTA (Drug) $428.51
- ARISTADA (Drug) $406.62
- TRINTELLIX (Drug) $394.82
- AUSTEDO (Drug) $343.39
- VYVANSE (Drug) $297.38
- ABILIFY MAINTENA (Drug) $225.61
- Dayvigo (Drug) $202.32
- Trintellix (Drug) $194.42
- Azstarys (Drug) $161.19
- VNS - Symmetry (Device) $149.80
- AZSTARYS (Drug) $136.07
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Houston
Dr. Lawrence Ginsberg, M.d, M.D
Psychiatry — Payments: $1.1M
Dr. Mazhar Khowaja
Psychiatry — Payments: $897,870
Barry Gritz, M.d, M.D
Psychiatry — Payments: $731,949
Dr. Frank Chen, Md Pa, MD PA
Psychiatry — Payments: $721,138
Dr. Aaron Peterson, Do, DO
Psychiatry — Payments: $549,804
Ayesha Rashid, M.d, M.D
Psychiatry — Payments: $445,948